Get started

Abbvie

AbbVie still bullish. ABBVGaining momentum and impulsing. This is good if you are bullish on this one. COVID paranoia is doing wonders for the pharma sector. It is very rare how a whole sector can benefit so much financially from mass hysteria. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NYSE:ABBVLong
by Rykin_Capital
2
AbbVie: Breakout! Buying a re-test of supportAbbVie - Short Term - We look to Buy at 119.00 (stop at 114.50) Previous resistance level of 119.95 broken. A move higher has resulted in prices breaking from the previous range and confirmed our bullish expectation. We have a Gap open at 118.86 from 03/12/2021 to 06/12/2021. Further upside is expected although we prefer to set longs at our bespoke support levels at 119.00, resulting in improved risk/reward. Our profit targets will be 135.00 and 150.00 Resistance: 122.42 / 124.00 / 130.00 Support: 119.95 / 118.86 / 115.03 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NYSE:ABBVLong
by Saxo
Weekly Outlook! 7/6 - 7/9Check out what stocks we are watching for the coming week! As well as a recap of last week's video! NYSE:ABBV We are looking for a breakout of it's current pennant pattern over the $115.60 area. We could see a return back to all time highs here NASDAQ:AMZN We are looking for a breakout of recent highs of $3525 for a re-test of all time highs, and ultimately a breakout of all time highs over $3554. NASDAQ:NFLX We are watching for a break of trend resistance over the $539 level for a gap fill up to $546 NYSE:SHOP We are watching this to break out of it's current bullflag pattern over $1500 for another move higher.
NYSE:SHOPLong
by ThirtyninethParallelInvestment
1
AbbVie Bearish Butterfly AbbVie has been on my radar now for quite a bit. It’s one of the few Pharm. companies Warren Buffet holds and even know I’m not strong in the realm of Pharm. I have seen their marketing on TV increase quite a bit. Since I am away from my computer at the moment and posting from the TradingView App. I do not know their financials right off hand. I will update this idea with that information later. However, here we have a bearish butterfly. The pattern panned out super nicely. Once the pattern completed it made a little bit of a consolidation and dropped yesterday heavily. I will be looking at buying some AbbVie once it hits the 618 of the pattern structure… if the movement looks weak (not likely based off the strong sell off with high volume) I think the 618 is likely. All the other numbers that made up the PRZ were over projections of the traditional ABCD pattern (2.0) and a 1.618 over extension. So the massive sell off with high volume is not surprising… be looking out later today for the financial report this does not mean I am saying AbbVie is going to the ground but it is a nice little correction that we long term investors can take advantage.
NYSE:ABBVShort
by ARegularGuy
1
ABBV, is it a buy right now?☝️ Losing patent protection for a top-selling blockbuster drug is a big setback for any pharmaceutical company, but this can also give us great opportunities. They have done a great strategic-movement by acquiring Allergan. It's down 18% from last July 17 high, earnings are close. I believe, yes, it's a good moment to START doing COST-AVERAGE. The price is almost getting closer to the 50% Fibonacci (from last Mar 20). I'm protecting an optimistic retracement to 127% (at $108.58) Fibonacci (drawing from today), very close to the analyst's current average price target at $109.21. A more conservative take profit would be at $95. - P/E GAAP (TTM) of 18.63, sector media of 35.57 👍 - Forward P/E of 6.94 👍 - PEG GAAP (TTM) of 0.29, sector media of 0.88 👍 - EV / EBITDA (TTM) of 13.76 in a sector media of 19.29 👍 - Debt / Eq of 5.4 😐 - Dividend yield of 5.60% 😍 Nothing else to say, it's a great company, with great dividends. I'm in! 👌 This isn't trading advice. I've no idea what I'm talking about 😉. Trade with caution! 🚨 Have a good day! 🤟
NYSE:ABBVLong
by UnknownUnicorn12013771
1
Potential LONG AbbVie Inc Stock After The Recent BreakoutThis week has been phenomenal for AbbVie Inc after researchers found that the large-cap pharma's cholesterol-lowering drug Tricor could work against SARS-CoV2, the virus that causes COVID-19. Key Trading Plan: Wait for the pull back to the Fibonacci 23% at 92.00 before the price rallies back up to the potential resistance of 106.00 ‼️Disclaimer: Please be advised that we are NOT Financial Advisors. We are not responsible for the results of your Forex or CFDs trading. The only person responsible for profits or losses is yourself. You should not consider any market information, educational and analytical material as trading advice that defines your trading actions but purely as educational market material. Please be advised that S.I.D. Capital shall not be liable for any errors in quotes and trading platform software errors. ‼️This Channel and all information is intended for educational purposes only and does not give financial advice. S.I.D. Capital Signals is not a service to provide legal and financial advice; any information provided here is only the personal opinion of the author (not advice or financial advice in any sense, and in the sense of any act, ordinance or law of any country) and must not be used for financial activities.
ALong
by SIDCapital
ABBV an Entry Point into the Wild World of BiotechBiotechnology and pharmaceutical companies have been quickly cycling through overbought and oversold. The problem has been so problematic that Sorrento Therapeutics had to specifically claim they were not a “pump and dump” scheme. Any whisper of a "cure" for Covid-19 has investors rushing to the entrance and quickly fleeing after results are what they had expected (an image of people rushing toward the exit and getting stuck in door comes to my mind). People who know the biotech sector have been cautiously watching the spectacle and trying to avoid getting trampled in a stampede. To be clear: your average investor is getting burned in the vaccine-hunt game. AbbVie "ABBV" is (and has been) a reliable pharmaceutical and biotechnology company for some time. The company is known for its generous dividend – previously at a yield of 5.20%. The company has a robust balance sheet with a Quick Ratio of 3.03 and a Current Ratio of 3.14. In the world of biotech, research and development is everything. ABBV pipeline is stacked with potential drug candidates many of which are in Phase 3 of development according to AbbVie’s investor relations brochure. From a technical analysis standpoint, the moving averages appear to be moving toward a positive crossover – EMA10 = 91.00, EMA20 = 90.88 EMA25 = 90.87. The stock does not look overbought or oversold according to the Stoch RSI and Money Flow Indicator. However, the MACD indicator shows that there may be a further swing downward before moving into positive territory. Finally, the linear regression model is one of the few biotechnology companies that is not inverse or appears caught in a sideway pattern. LONG ABBV purchased today (06-02-2020) @ 90.86.
NYSE:ABBVLong
by luminaryfi
6
ABBV - Letting it Come in for a Better EntryOne of my absolute favorite stocks for the next 3 years: ABBV. I'm letting it come down a bit before initiating a position. My model says that there is going to be heavy buying between 74 and 79 which is where I will start accumulation. If you found this to be insightful or helpful, please show appreciation by hitting that like button. If you want more ideas I invite you to follow as well! I try to be here for all of my followers with any questions they might have. Feel free to shoot me a DM or comment below to start a conversation!
NYSE:ABBVLong
by chartsareforships
1